Page 55 - Read Online

Page 14 of 15 Pintos-Morell et al. Rare Dis Orphan Drugs J 2024;3:12 https://dx.doi.org/10.20517/rdodj.2023.52

REFERENCES
1. Ferreira CR, van Karnebeek CDM, Vockley J, Blau N. A proposed nosology of inborn errors of metabolism. Genet Med 2019;21:102-
6. DOI PubMed PMC
2. Ferreira CR, Rahman S, Keller M, Zschocke J; ICIMD Advisory Group. An international classification of inherited metabolic
disorders (ICIMD). J Inherit Metab Dis 2021;44:164-77. DOI PubMed PMC
3. Cani I, Pondrelli F, Licchetta L, et al. Epilepsy and inborn errors of metabolism in adults: the diagnostic odyssey of a young woman
with medium-chain acyl-coenzyme A dehydrogenase deficiency. Epilepsia Open 2022;7:810-6. DOI PubMed PMC
4. la Marca G, Carling RS, Moat SJ, et al. Current state and innovations in Newborn Screening: continuing to do good and avoid harm.
Int J Neonatal Screen 2023;9:15. DOI PubMed PMC
5. Bick D, Ahmed A, Deen D, et al. Newborn screening by genomic sequencing: opportunities and challenges. Int J Neonatal Screen
2022;8:40. DOI PubMed PMC
6. Stark Z, Scott RH. Genomic newborn screening for rare diseases. Nat Rev Genet 2023;24:755-66. DOI PubMed
7. Jones SA, Cheillan D, Chakrapani A, et al. Application of a novel algorithm for expanding newborn screening for inherited metabolic
disorders across Europe. Int J Neonatal Screen 2022;8:20. DOI PubMed PMC
8. Burlina A, Jones SA, Chakrapani A, et al. A new approach to objectively evaluate inherited metabolic diseases for inclusion on
newborn screening programmes. Int J Neonatal Screen 2022;8:25. DOI PubMed PMC
9. Lee H, Deignan JL, Dorrani N, et al. Clinical exome sequencing for genetic identification of rare Mendelian disorders. JAMA
2014;312:1880-7. DOI PubMed PMC
10. Yubero D, Brandi N, Ormazabal A, et al; Working Group. Targeted next generation sequencing in patients with inborn errors of
metabolism. PLoS One 2016;11:e0156359. DOI PubMed PMC
11. Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics
1963;32:338-43. DOI PubMed
12. Blau N, van Spronsen FJ, Levy HL. Phenylketonuria. Lancet 2010;376:1417-27. DOI PubMed
13. Therrell BL, Padilla CD, Loeber JG, et al. Current status of newborn screening worldwide: 2015. Semin Perinatol 2015;39:171-87.
DOI
14. Kelly N, Makarem DC, Wasserstein MP. Screening of newborns for disorders with high benefit-risk ratios should be mandatory. J Law
Med Ethics 2016;44:231-40. DOI PubMed PMC
15. Liu N, Xiao J, Gijavanekar C, et al. Comparison of untargeted metabolomic profiling vs traditional metabolic screening to identify
inborn errors of metabolism. JAMA Netw Open 2021;4:e2114155. DOI PubMed PMC
16. Gelb MH, Lukacs Z, Ranieri E, Schielen PCJI. Newborn screening for lysosomal storage disorders: methodologies for measurement of
enzymatic activities in dried blood spots. Int J Neonatal Screen 2019;5:1. DOI PubMed PMC
17. Bonaventura E, Alberti L, Lucchi S, et al; XALD-NBS Study Group. Newborn screening for X-linked adrenoleukodystrophy in Italy:
diagnostic algorithm and disease monitoring. Front Neurol 2022;13:1072256. DOI PubMed PMC
18. Loeber JG, Platis D, Zetterström RH, et al. Neonatal screening in Europe revisited: an ISNS perspective on the current state and
developments Since 2010. Int J Neonatal Screen 2021;7:15. DOI PubMed PMC
19. Castiñeras DE, Couce ML, Marin JL, González-Lamuño D, Rocha H. Newborn screening for metabolic disorders in Spain and
worldwide. An Pediatr 2019;91:128.e1-14. DOI PubMed
20. Grupo de trabajo del Sistema de Información del Programa de Cribado Neonatal del SNS. Programa de cribado neonatal del sistema
nacional de salud. Informe de Evaluación. Año 2019. Ministerio de Sanidad, 2021. Available from: https://cpage.mpr.gob.es/producto/
programa-cribado-neonatal-del-sistema-nacional-de-salud/ [Last accessed on 23 Apr 2024].
21. Valcárcel-Nazco C, García-Pérez L, Linertová R, et al. Development of newborn screening policies in Spain 2003-2022: what do we
actually need to reach an agreement? Rare Dis Orphan Drugs J 2023; 2:19. DOI
22. Giżewska M, van Wegberg AMJ, Maillot F, Trefz F, van Spronsen FJ. Caring for Ukrainian refugee children with acute and chronic
diseases. Lancet 2022;399:1689. DOI PubMed
23. Scarpa M, Bonham JR, Dionisi-Vici C, et al. Newborn screening as a fully integrated system to stimulate equity in neonatal screening
in Europe. Lancet Reg Health Eur 2022;13:100311. DOI PubMed PMC
24. Sikonja J, Groselj U, Scarpa M, et al. Towards achieving equity and innovation in newborn screening across Europe. Int J Neonatal
Screen 2022;8:31. DOI PubMed PMC
25. Tayoun AN. Unequal global implementation of genomic newborn screening. Nat Rev Genet 2023;24:801-2. DOI PubMed
26. McHugh D, Cameron CA, Abdenur JE, et al. Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by
tandem mass spectrometry: a worldwide collaborative project. Genet Med 2011;13:230-54. DOI PubMed
27. Siri B, Olivieri G, Angeloni A, et al. The diagnostic challenge of mild citrulline elevation at newborn screening. Mol Genet Metab
2022;135:327-32. DOI
28. Auray-Blais C, Boutin M, Lavoie P, Maranda B. Neonatal urine screening program in the province of Quebec: technological upgrade
from thin layer chromatography to tandem mass spectrometry. Int J Neonatal Screen 2021;7:18. DOI PubMed PMC
29. Dimmock D, Caylor S, Waldman B, et al. Project baby bear: rapid precision care incorporating rWGS in 5 California children’s
hospitals demonstrates improved clinical outcomes and reduced costs of care. Am J Hum Genet 2021;108:1231-8. DOI PubMed
PMC
30. Tangeraas T, Saeves I, Klingenberg C, et al. Performance of expanded newborn screening in Norway supported by post-analytical